Gerresheimer at Compamed: seamless transition from development to robust mass production

Gerresheimer at Compamed: seamless transition from development to robust mass production
Gerresheimer at Compamed: seamless transition from development to robust mass production

Gerresheimer manufactures innovative drug delivery systems as well as medical devices and diagnostic products for brand name customers all over the world. It is a full-service provider covering all stages of the supply chain up to finished CE-marked product, from concept development, industrial design, product development, production equipment engineering, mould engineering and special equipment production to FDA and GMP-compliant large and small series production, assembly, pharmaceutics assembly and filling, sterilization and packaging.

“One of our strengths is that we offer a seamless transition from development to robust mass manufacturing,” said Peter Wallrabe, Managing Director of Gerresheimer Item in Münster, Germany. At Compamed in Düsseldorf, the international trade fair for suppliers and manufacturers of medical technology, Gerresheimer will be demonstrating its expertise in usability engineering, industrial design, product development, mould engineering, automation technology, injection moulding in clean room environments, assembly, finishing, pharmaceutics assembly, packing and filling.

Medical products are becoming increasingly complex. Patients using the products are also getting older, and an increasing number of people are self-medicating in the home. Medical personnel are faced with time constraints and pressure to work more efficiently. Various factors can contribute to mistakes being made in the use of medical products, which is why usability engineering is coming Gerresheimer at Compamed: seamless transition from development to robust mass productionto play a key role. The FDA’s audits today have a stronger usability focus, so Gerresheimer’s specially trained usability engineers work with its customers to incorporate usability considerations at an early stage of the product development process. They analyze users, use context and products that are already available in the market, interview experts, conduct user tests, draw up interaction specifications and perform many other activities. At the end of the product development process, Gerresheimer’s customers don’t just get a medical device that is optimally geared to patient requirements – user friendly, intuitive and safe – but can also be mass manufactured.

COMPAMED in Düsseldorf
November 14-17, 2016
Hall 8b, Stand K17

Further information

Gerresheimer Medical Systems - Product Design and Development

About Gerresheimer

Gerresheimer is a leading global partner to the pharma and healthcare industries. The company’s special glass and plastic products contribute to health and well-being. Gerresheimer is a global organization with about 10.000 employees and manufacturing operations in the local markets, close to customers. With plants in Europe, North and South America and Asia Gerresheimer generates revenues in excess of EUR 1.4 billion. The comprehensive product portfolio includes pharmaceutical packaging products as well as convenient and safe drug delivery systems such as insulin pens, inhalers, pre-fillable syringes, vials, ampoules, bottles and containers for liquid and solid pharmaceuticals with closure and safety systems, plus cosmetic packaging products.

Contact us!

Communication & Marketing
Phone: +49 211 61 81 251
E-Mail: ueli.utzinger-remove@remove-gerresheimer.com